Martin J. Madden

Martin Madden has been a director of Novocure since 2017. Mr. Madden retired after a 30-year career at Johnson & Johnson (from 1986 to 2017), where he  served as Vice President of R&D for DePuy-Synthes and Vice President of Medical Device R&D Transformation from February 2016 to January 2017; as Vice President of New Product Development, Medical Devices from July 2015 to February 2016; and as Vice President of R&D for the Global Surgery Group from January 2012 to July 2015. Earlier in his career, Mr. Madden was a medical device engineer and innovator and a leader of cross-functional teams charged with incubating, developing, and launching new products. He also serves on the board of Microbot Medical Inc. and is formerly a director of TSO3, Inc. (acquired). Mr. Madden holds a Bachelor’s degree in Mechanical Engineering from the University of Dayton, a Master’s degree in Mechanical Engineering from Carnegie-Mellon University, and an MBA from Columbia University.